NanoViricides, Inc. (NNVC)
NYSEAMERICAN: NNVC · Real-Time Price · USD
1.190
+0.030 (2.59%)
Nov 18, 2026, 4:00 PM EST - Market closed
NanoViricides Employees
NanoViricides had 7 employees as of June 30, 2026. The number of employees did not change compared to the previous year. That makes NanoViricides the 41,107th largest employer in the world and 6,245th in the United States.
Employees
7
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,739,484
Market Cap
30.37M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 7 | 0 | - |
| Jun 30, 2025 | 7 | 0 | - |
| Jun 30, 2024 | 7 | 0 | - |
| Jun 30, 2023 | 7 | -10 | -58.82% |
| Jun 30, 2022 | 17 | 0 | - |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| EyePoint | 214 |
| Adicet Bio | 102 |
| NextCure | 40 |
| eXoZymes | 32 |
| BriaCell Therapeutics | 31 |
| INmune Bio | 21 |
| LeonaBio | 19 |
| ProMIS Neurosciences | 11 |
NNVC News
- 1 day ago - NanoViricides reports Q1 EPS (23c) vs. (10c) last year - TheFly
- 22 days ago - NanoViricides says Phase IIa trial of NV-387 in ebola âprogressing wellâ - TheFly
- 4 weeks ago - NanoViricides says NV-387 demonstrates âstrongâ parameters in animal model study - TheFly
- 4 weeks ago - NanoViricides' Revolutionary Broad-Spectrum Drug Candidate NV-387 Has Successfully Demonstrated Excellent Indications for Safety and Toxicology in a Juvenile Mouse Pups Animal Study, Paving the Way for Pediatric Use in Clinical Trials - Accesswire
- 5 weeks ago - NanoViricides announces Phase IIA Ebola trial of NV-387 is progressing well - TheFly
- 5 weeks ago - Phase II Clinical Trial of NV-387 Oral Gummies as Treatment of Ebola Progressing Well, Says NanoViricides - Accesswire
- 6 weeks ago - NanoViricides Presenting at NIBA's 153rd Investment Conference in Fort Lauderdale, FL October 7, 2026 - Accesswire
- 6 weeks ago - NanoViricides says Phase II trial of NV-387 in ebola âproceeding as designedâ - TheFly